1887
  1. Home
  2. Eurosurveillance
  3. Volume 23, Issue 11, 15/Mar/2018
  4. Article
Surveillance and outbreak report Open Access
Like 0
Download

Abstract

We evaluated uptake and diagnostic outcomes of voluntary hepatitis B (HBV) and C virus (HCV) screening offered during routine tuberculosis entry screening to migrants in Gelderland and Amsterdam, the Netherlands, between 2013 and 2015. In Amsterdam, HIV screening was also offered. Overall, 54% (461/859) accepted screening. Prevalence of chronic HBV infection (HBsAg-positive) and HCV exposure (anti-HCV-positive) in Gelderland was 4.48% (9/201; 95% confidence interval (CI): 2.37–8.29) and 0.99% (2/203; 95% CI: 0.27–3.52), respectively, all infections were newly diagnosed. Prevalence of chronic HBV infection, HCV exposure and chronic HCV infection (HCV RNA-positive) in Amsterdam was 0.39% (1/256; 95% CI: 0.07–2.18), 1.17% (3/256; 95% CI: 0.40–3.39) and 0.39% (1/256; 95% CI: 0.07–2.18), respectively, with all chronic HBV/HCV infections previously diagnosed. No HIV infections were found. In univariate analyses, newly diagnosed chronic HBV infection was more likely in participants migrating for reasons other than work or study (4.35% vs 0.83%; odds ratio (OR) = 5.45; 95% CI: 1.12–26.60) and was less likely in participants in Amsterdam than Gelderland (0.00% vs 4.48%; OR = 0.04; 95% CI: 0.00–0.69). Regional differences in HBV prevalence might be explained by differences in the populations entering compulsory tuberculosis screening. Prescreening selection of migrants based on risk factors merits further exploration.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2018.23.11.17-00491
2018-03-15
2024-12-26
/content/10.2807/1560-7917.ES.2018.23.11.17-00491
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/23/11/eurosurv-23-11-4.html?itemId=/content/10.2807/1560-7917.ES.2018.23.11.17-00491&mimeType=html&fmt=ahah

References

  1. Hahné SJ, De Melker HE, Kretzschmar M, Mollema L, Van Der Klis FR, Van Der Sande MA, et al. Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007. Epidemiol Infect. 2012;140(8):1469-80.  https://doi.org/10.1017/S095026881100224X  PMID: 22078095 
  2. Willemse SB, Razavi-Shearer D, Zuure FR, Veldhuijzen IK, Croes EA, van der Meer AJ, et al. The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms. Neth J Med. 2015;73(9):417-31. PMID: 26582807 
  3. van Sighem AI, Boender TS, Wit FWNM, Smit C, Matser A, Reiss P. HIV monitoring report 2017. Human immunodeficiency virus (HIV) infection in the Netherlands. In: Amsterdam: Stichting HIV Monitoring; 2017. Available from: https://www.hiv-monitoring.nl/files/1115/1117/7706/HIV_Monitoring_Report_2017.pdf
  4. Vriend HJ, Van Veen MG, Prins M, Urbanus AT, Boot HJ, Op De Coul EL. Hepatitis C virus prevalence in The Netherlands: migrants account for most infections. Epidemiol Infect. 2013;141(6):1310-7.  https://doi.org/10.1017/S0950268812001884  PMID: 22963908 
  5. van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, et al. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology. 2004;39(3):804-10.  https://doi.org/10.1002/hep.20128  PMID: 14999700 
  6. van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012;308(24):2584-93.  https://doi.org/10.1001/jama.2012.144878  PMID: 23268517 
  7. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.  https://doi.org/10.1056/NEJMoa1105243  PMID: 21767103 
  8. Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795-807.  https://doi.org/10.1056/NEJMoa1506816  PMID: 26192873 
  9. Urbanus AT, Steenbergen JE. Hepatitis B-virus en hepatitis C-virus screeningsprojecten voor migranten in Nederland: stand van zaken 2014. [Hepatitis B virus and hepatitis C virus screening projects for migrants in the Netherlands: status 2014]. Tijdschrift voor Infectieziekten. 2015;10(2):31-6. Dutch.
  10. Zuure FR, Bouman J, Martens M, Vanhommerig JW, Urbanus AT, Davidovich U, et al. Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands. Liver Int. 2013;33(5):727-38.  https://doi.org/10.1111/liv.12131  PMID: 23448397 
  11. Veldhuijzen IK, Wolter R, Rijckborst V, Mostert M, Voeten HA, Cheung Y, et al. Identification and treatment of chronic hepatitis B in Chinese migrants: results of a project offering on-site testing in Rotterdam, The Netherlands. J Hepatol. 2012;57(6):1171-6.  https://doi.org/10.1016/j.jhep.2012.07.036  PMID: 22885717 
  12. Richter C, Ter Beest G, Gisolf EH, VAN Bentum P, Waegemaekers C, Swanink C, et al. Screening for chronic hepatitis B and C in migrants from Afghanistan, Iran, Iraq, the former Soviet Republics, and Vietnam in the Arnhem region, The Netherlands. Epidemiol Infect. 2014;142(10):2140-6.  https://doi.org/10.1017/S0950268813003415  PMID: 24398373 
  13. Richter C, Beest GT, Sancak I, Aydinly R, Bulbul K, Laetemia-Tomata F, et al. Hepatitis B prevalence in the Turkish population of Arnhem: implications for national screening policy? Epidemiol Infect. 2012;140(4):724-30.  https://doi.org/10.1017/S0950268811001270  PMID: 21740610 
  14. van der Veen YJ, van Empelen P, de Zwart O, Visser H, Mackenbach JP, Richardus JH. Cultural tailoring to promote hepatitis B screening in Turkish Dutch: a randomized control study. Health Promot Int. 2014;29(4):692-704.  https://doi.org/10.1093/heapro/dat020  PMID: 23574695 
  15. Niessen W, Benne R, van Zeijl J, van der Have J, Broer J. Is het schriftelijk oproepen van immigranten voor hepatitis B-onderzoek effectief? [Is a written call of immigrants for hepatitis B examination effective?]. Infectieziekten Bulletin. 2013;24(4):107-12. Dutch.
  16. Coenen S, van Meer S, Vrolijk JM, Richter C, van Erpecum KJ, Mostert MC, et al. Clinical impact of five large-scale screening projects for chronic hepatitis B in Chinese migrants in the Netherlands. Liver Int. 2016;36(10):1425-32.  https://doi.org/10.1111/liv.13125  PMID: 27001619 
  17. Menger H, Neve G. ‘Vietnam tussen de tulpen’ Screening op hepatitis B van Vietnamese inwoners van Noord-Holland. [‘Vietnam among the tulips' Screening for hepatitis B of Vietnamese inhabitants of North Holland]. Infectieziekten Bulletin. 2013;24(2):45-7. Dutch.
  18. Grintjes MANP, Dofferhoff ASM, Stelma F, Koene RPM, van Crevel R, van den Muijsenbergh M, et al. Hepatitis C-opsporing onder migranten in Nijmegen (HECOM). [Hepatitis C detection among migrants in Nijmegen (HECOM)]. Tijdschrift voor Infectieziekten. 2014;9(5). Dutch.
  19. de Vries G, Riesmeijer R. National Tuberculosis Control Plan 2016-2020: Towards elimination. Bilthoven: National Institute for Public Health and the Environment, Ministry of Health, Welfare and Sport; 2016. Available from: https://www.rivm.nl/bibliotheek/rapporten/2016-0012.html
  20. World Health Organization (WHO). WHO regional offices. Geneva: WHO. (Accessed: 30 Sep 2016). Available from: http://www.who.int/about/regions/en/
  21. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-55.  https://doi.org/10.1016/S0140-6736(15)61412-X  PMID: 26231459 
  22. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1) Suppl;S45-57.  https://doi.org/10.1016/j.jhep.2014.07.027  PMID: 25086286 
  23. Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, et al. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV. 2016;3(8):e361-87.  https://doi.org/10.1016/S2352-3018(16)30087-X  PMID: 27470028 
  24. Fernandez M, Manzanares S, Jacques C, Caylá J, Rossi M, Thomson R, et al. Screening for chronic viral hepatitis in migrant populations. Report on four HEPscreen pilot studies. Rotterdam: HEPscreen; 2014. Available from: http://hepscreen.eu/wp-content/uploads/2014/12/HEPscreen_Final-WP6-report_Pilot-studies.pdf
  25. Op de Coul EL, Hahné S, van Weert YW, Oomen P, Smit C, van der Ploeg KP, et al. Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective. BMC Infect Dis. 2011;11(1):185.  https://doi.org/10.1186/1471-2334-11-185  PMID: 21718466 
  26. Heijman RL, Stolte IG, Thiesbrummel HF, van Leent E, Coutinho RA, Fennema JS, et al. Opting out increases HIV testing in a large sexually transmitted infections outpatient clinic. Sex Transm Infect. 2009;85(4):249-55.  https://doi.org/10.1136/sti.2008.033258  PMID: 19103642 
  27. Mulder-Folkerts DK, van den Hoek JA, van der Bij AK, Boer K, Schutte MF, Coutinho RA. Minder weigering van deelname aan HIV-screening door zwangeren in Amsterdam sedert de invoering van de standaard-HIV-screening--tenzij weigering (‘opting-out’-methode). [Less refusal to participate in HIV screening among pregnant women in the Amsterdam region since the introduction of standard HIV screening using the opting-out method]. Ned Tijdschr Geneeskd. 2004;148(41):2035-7. Dutch. PMID: 15554003 
  28. Veldhuijzen IK, Toy M, Hahné SJ, De Wit GA, Schalm SW, de Man RA, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology. 2010;138(2):522-30.  https://doi.org/10.1053/j.gastro.2009.10.039  PMID: 19879275 
  29. Zuure FR, Urbanus AT, Langendam MW, Helsper CW, van den Berg CH, Davidovich U, et al. Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review. BMC Public Health. 2014;14(1):66.  https://doi.org/10.1186/1471-2458-14-66  PMID: 24450797 
  30. van Veen MG, Trienekens SC, Heijman T, Gotz HM, Zaheri S, Ladbury G, et al. Delayed linkage to care in one-third of HIV-positive individuals in the Netherlands. Sex Transm Infect. 2015;91(8):603-9.  https://doi.org/10.1136/sextrans-2014-051980  PMID: 25964506 
  31. Scheppers E, van Dongen E, Dekker J, Geertzen J, Dekker J. Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract. 2006;23(3):325-48.  https://doi.org/10.1093/fampra/cmi113  PMID: 16476700 
Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Janneke+P+Bil&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bil Janneke P</a>, <a href="/search?value1=Peter+AG+Schrooders&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Schrooders Peter AG</a>, <a href="/search?value1=Maria+Prins&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Prins Maria</a>, <a href="/search?value1=Peter+M+Kouw&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kouw Peter M</a>, <a href="/search?value1=Judith+HE+Klomp&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Klomp Judith HE</a>, <a href="/search?value1=Maarten+Scholing&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Scholing Maarten</a>, <a href="/search?value1=Lutje+PHM+Huijbregts&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Huijbregts Lutje PHM</a>, <a href="/search?value1=Gerard+JB+Sonder&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sonder Gerard JB</a>, <a href="/search?value1=Toos+CHFM+Waegemaekers&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Waegemaekers Toos CHFM</a>, <a href="/search?value1=Henry+JC+de+Vries&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Vries Henry JC</a>, <a href="/search?value1=Wieneke+Meijer&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Meijer Wieneke</a>, <a href="/search?value1=Freke+R+Zuure&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Zuure Freke R</a>, <a href="/search?value1=Alma+Tostmann&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Tostmann Alma</a></span>. Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015. <a href="/content/ecdc">Euro Surveill.</a> 2018;23(11):pii=17-00491. <a href="https://doi.org/10.2807/1560-7917.ES.2018.23.11.17-00491" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2018.23.11.17-00491</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 20 Jul 2017;&nbsp;&nbsp; <span class="generated">Accepted</span>: 27 Feb 2018 </span> </p>
/content/10.2807/1560-7917.ES.2018.23.11.17-00491
/content/10.2807/1560-7917.ES.2018.23.11.17-00491
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error